Therapeutic plasma exchange performed in parallel with extra corporeal membrane oxygenation for antibody mediated rejection after heart transplantation

Journal of Clinical Apheresis

Volumn 22, Issue 6, 2007, Pages 333-338

  Jhang, Jeffrey ^a   Middlesworth, William ^b   Shaw, Rose ^c   Charette, Kevin ^b   Papa, Joey ^b   Jefferson, Rashida ^b   Torloni, Antonio S ^d   Schwartz, Joseph ^a  

^a NewYork Presbyterian Hospital   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c HemaCare Corporation   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Acute humoral rejection; Anti HLA antibodies; Antibody mediated rejection; Extracorporeal membrane oxygenation; Heart transplantation

Indexed keywords

ADULT; ANTIBODY TITER; ARTICLE; CARDIAC GRAFT REJECTION; CASE REPORT; CONGESTIVE HEART FAILURE; EXTRACORPOREAL OXYGENATION; FEASIBILITY STUDY; FEMALE; HEART ARRHYTHMIA; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HUMAN; INFANT; MALE; PLASMA VOLUME; PLASMAPHERESIS; PRESCHOOL CHILD; RESPIRATORY DISTRESS SYNDROME; SAFETY; TREATMENT OUTCOME;

ADULT; DIGEORGE SYNDROME; EXTRACORPOREAL MEMBRANE OXYGENATION; FATAL OUTCOME; FEMALE; GRAFT REJECTION; HEART SEPTAL DEFECTS; HEART TRANSPLANTATION; HEART VENTRICLES; HLA ANTIGENS; HUMANS; INFANT; MALE; OXYGEN; PLASMA EXCHANGE;

EID: 38949180270     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20151     Document Type: Article

References (38)

1. Hammond EH, Ensley RD, Yowell RL, Craven CM, Bristow MR, Renlund DG, O'Connell JB. Vascular rejection of human cardiac allografts and the role of humoral immunity in chronic allograft rejection. Transplant Proc 1991;23 (2 Suppl 2):26-30.
2. Michaels PJ, Fishbein MC, Colvin RB. Humoral rejection of human organ transplants. Springer Semin Immunopathol 2003;25:119-140.
3. Michaels PJ, Espejo ML, Kobashigawa J, Alejos JC, Burch C, Takemoto S, Reed EF, Fishbein MC. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 2003;22:58-69.
4. Hammond EH, Yowell RL, Nunoda S, Menlove RL, Renlund DG, Bristow MR, Gay WA, Jr., Jones KW, O'Connell JB. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant 1989;8:430-443.
5. Takemoto SK, Zeevi A, Feng S, Colvin RB, Jordan S, Kobashigawa J, Kupiec-Weglinski J, Matas A, Montgomery RA, Nickerson P, Platt JL, Rabb H, Thistlethwaite R, Tyan D, Delmonico FL. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004;4:1033-1041.
6. Cherry R, Nielsen H, Reed E, Reemtsma K, Suciu-Foca N, Marboe CC. Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies. J Heart Lung Transplant 1992;11 (1 Pt 1):24-29; discussion 30.
7. Mahle WT, Naftel DC, Rusconi P, Edens RE, Shaddy RE. Panel-reactive antibody cross-reactivity and outcomes in the pediatric heart transplant study. J Heart Lung Transplant 2004;23:S167.
8. Pisani BA, Mullen GM, Malinowska K, Lawless CE, Mendez J, Silver MA, Radvany R, Robinson JA. Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. J Heart Lung Transplant 1999;18:701-706.
9. Mitchell MB, Campbell DN, Bielefeld MR, Doremus T. Utility of extracorporeal membrane oxygenation for early graft failure following heart transplantation in infancy. J Heart Lung Transplant 2000;19:834-839.
10. Galantowicz ME, Stolar CJ. Extracorporeal membrane oxygenation for perioperative support in pediatric heart transplantation. J Thorac Cardiovasc Surg 1991;102:148-151; discussion 151-152.
11. Mahmood A, Sodano D, Dash A, Weinstein R. Therapeutic plasma exchange performed in tandem with hemodialysis for patients with M-protein disorders. J Clin Apher 2006;21:100-104.
12. Bhowmik D, Jain PK, Masih JA, Saha D, Gupta S, Agarwal SK, Tiwari SC, Dash SC. Tandem plasmapheresis and hemodialysis. Ther Apher 2001;5:439-441.
13. Agarwal HS, Taylor MB, Grzeszczak MJ, Lovvorn HN, Hunley TE, Jabs K, Shankar V. Extra corporeal membrane oxygenation and plasmapheresis for pulmonary hemorrhage in microscopic polyangiitis. Pediatr Nephrol 2005;20:526-528.
14. Vasilescu ER, Ho EK, Colovai AI, Vlad G, Foca-Rodi A, Markowitz GS, D'Agati V, Hardy MA, Ratner LE, Suciu-Foca N. Alloantibodies and the outcome of cadaver kidney allografts. Hum Immunol 2006;67:597-604.
15. Caple J, McMahon J, Myles J, Hook S, Ratliff N. Acute vascular (humoral) rejection in non-OKT3-treated cardiac transplants. Cardiovasc Pathol 1995;4:13-18.
16. Crespo-Leiro MG, Veiga-Barreiro A, Domenech N, Paniagua MJ, Pinon P, Gonzalez-Cuesta M, Vazquez-Martul E, Ramirez C, Cuenca JJ, Castro-Beiras A. Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis. Am J Transplant 2005;5:2560-2564.
17. Ballew CC, Bergin JD. Management of patients with preformed reactive antibodies who are awaiting cardiac transplantation. Am J Crit Care 2005;14:46-51.
18. Chen YS, Yu HY, Huang SC, Chiu KM, Lin TY, Lai LP, Lin FY, Wang SS, Chu SH, Ko WJ. Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: what mechanical support should be considered first? J Heart Lung Transplant 2005;24:81-87.
19. Gonzalez-Stawinski GV, Atik FA, McCarthy PM, Roselli EE, Hoercher K, Navia JL, Smedira NG, Starling RC, Young JB, Cook DJ. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices. Transplant Proc 2005;37:1349-1351.
20. Jacobs JP, Quintessenza JA, Boucek RJ, Morell VO, Botero LM, Badhwar V, van Gelder HM, Asante-Korang A, McCormack J, Daicoff GR. Pediatric cardiac transplantation in children with high panel reactive antibody. Ann Thorac Surg 2004;78:1703-1709.
21. Tambur AR, Bray RA, Takemoto SK, Mancini M, Costanzo MR, Kobashigawa JA, D'Amico CL, Kanter KR, Berg A, Vega JD, Smith AL, Roggero AL, Ortegel JW, Wilmoth-Hosey L, Cecka JM, Gebel HM. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation 2000;70:1055-1059.
22. Tambur AR, Pamboukian SV, Costanzo MR, Herrera ND, Dunlap S, Montpetit M, Heroux A. The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation 2005;80:1019-1025.
23. Malafa M, Mancini MC, Myles JL, Gohara A, Dickinson JM, Walsh TE. Successful treatment of acute humoral rejection in a heart transplant patient. J Heart Lung Transplant 1992;11 (3 Pt 1):486-491.
24. Shaddy RE, Fuller TC. The sensitized pediatric heart transplant candidate: causes, consequences, and treatment options. Pediatr Transplant 2005;9:208-214.
25. Wang SS, Chou NK, Ko WJ, Chi NH, Hung SC, Hsu RB, Yu HY, Chen YS, Chu SH, Tsao CI, Shun CT. Effect of plasma-pheresis for acute humoral rejection after heart transplantation. Transplant Proc 2006;38:3692-3694.
26. Ratkovec RM, Hammond EH, O'Connell JB, Bristow MR, DeWitt CW, Richenbacher WE, Millar RC, Renlund DG. Outcome of cardiac transplant recipients with a positive donor-specific crossmatch - preliminary results with plasmapheresis. Transplantation 1992;54:651-655.
27. Robinson JA, Radvany RM, Mullen MG, Garrity ER, Jr., Plasmapheresis followed by intravenous immunoglobulin in presensitized patients awaiting thoracic organ transplantation. Ther Apher 1997;1:147-151.
28. Robinson JA. Apheresis in thoracic organ transplantation. Ther Apher 1999;3:34-39.
29. Bucin D, Johansson S, Malm T, Jogi P, Johansson J, Westrin P, Lindberg LO, Olsson AK, Gelberg J, Peres V, Harling S, Bennhagen R, Kornhall B, Ekmehag B, Kurkus J, Otto G. Heart transplantation across the antibodies against HLA and ABO. Transpl Int 2006;19:239-244.
30. Leech SH, Lopez-Cepero M, LeFor WM, DiChiara L, Weston M, Furukawa S, Macha M, Singhal A, Wald JW, Nikolaidis LA, McClurken JB, Bove AA. Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin. Clin Transplant 2006;20:476-484.
31. Pahl E, Naftel DC, Kuhn MA, Shaddy RE, Morrow WR, Canter CE, Kirklin J. The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study. J Heart Lung Transplant 2005;24:645-651.
32. Botha P, Hasan A, Haynes S, Cassidy J, Roe J, Wallis J, Smith J. Exchange transfusion during extra corporeal membrane oxygenation used as a bridge to ABO-mismatch cardiac transplantation. Ann Thorac Surg 2006;81:1105-1107.
33. Singh N. Infectious complications in organ transplant recipients with the use of calcineurin-inhibitor agent-based immunosuppressive regimens. Curr Opin Infect Dis 2005;18:342-345.
34. Gomez-Moreno S, Lage E, Jimenez-Jambrina M, Ordonez A, Borrego JM, Hernandez A, Cayuela A, Cisneros JM. Infections in cardiac transplant recipients: clinical and microbiological characteristics and consequences. Transplant Proc 2006;38:2555-2557.
35. Mattner F, Fischer S, Weissbrodt H, Chaberny IF, Sohr D, Gottlieb J, Welte T, Henke-Gendo C, Gastmeier P, Strueber M. Post-operative nosocomial infections after lung and heart transplantation. J Heart Lung Transplant 2007;26:241-249.
36. Wing EJ, Bruns FJ, Fraley DS, Segel DP, Adler S. Infectious complications with plasmapheresis in rapidly progressive glomerulonephritis. JAMA 1980;244:2423-2426.
37. Aringer M, Smolen JS, Graninger WB. Severe infections in plasmapheresis-treated systemic lupus erythematosus. Arthritis Rheum 1998;41:414-420.
38. Pohl MA, Lan SP, Berl T. Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. Ann Intern Med 1991;114:924-929.